CASE REPORT: SYMMETRIC FLEXURAL EXANTHEMA TO DICLOFENAC by Dr Paul Henry
  International Journal of Medical Studies: BRAINYBUZZ PUBLICATION HUB                                         68        
 
International Journal of Medical Studies                  Print ISSN   2542-2766 
Brainybuzz Publication Hub                                                                           
 
Original Article                    IJMS SEP 2016/ Vol 1/Issue 9 
CASE REPORT: SYMMETRIC FLEXURAL EXANTHEMA TO DICLOFENAC 
Dr Paul Henry 
Assistant Professor, School of medicine, Namibia 
 
Corresponding author:  Dr Paul Henry, drpaulhpaulkmucn6@yahoo.com 
 
ABSTRACT 
Symmetric intertriginous and flexural exanthema (SDRIFE) is a rare  self limiting drug reaction characteristically 
affecting the intertriginous areas.  The common offending drugs are aminopencillins, beta lactam antibiotics 
and chemotherapeutic agents. 
Here we report a 68 year old male  who developed  well defined  symmetric  erosions involving bilateral axilla, 
upper and inner thighs and  genitalia with  dusky hue of  the surrounding skin and mucosal lesions after twelve 
hours  of  intake of  diclofenac  sodium. One year later on re exposure to the same drug, he developed an 
exactly similar clinical picture . Patient recovered with hyperpigmentation during both the episodes   on   
withdrawal of the offending drug and administration of systemic steroids. To the best of our knowledge,   this 
is the first report of  recurrent SDRIFE to diclofenac sodium with unusual features of erosive lesions ,mucosal 
involvement and the striking resemblance to fixed drug eruption. 
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INTRODUCTION 
Drug reactions are often a diagnostic enigma which present with various morphological 
patterns mimicking other dermatosis. Symmetric intertriginous and flexural exanthema 
(SDRIFE) is a rare   self limiting drug reaction characteristically affecting the intertriginous 
areas seen predominantly in middle aged males [1]. Here we report a patient who 
developed recurrent episodes of SDRIFE following intake of diclofenac, which subsided with 




Available online 30 september 2016
                                                                                         IJMS SEP 2016/ Vol 1/Issue 9 
 
International Journal of Medical Studies: BRAINYBUZZ PUBLICATION HUB                                          69 
 
Case report 
A 76-year old male presented with redness   and erosions affecting both axillae , upper and 
inner thighs and  genitalia of two days duration without any constitutional symptoms. There 
was no personal or family history of drug reactions. The patient gave a history of low back 
ache following a trauma one week back. There was no history of any   topical applications. 
But   the patient had taken four tablets of diclofenac sodium in the past two days. Twelve 
hours   after the first dose of diclofenac, intense erythema appeared over the axillae, groins 
and genitalia, which then progressed to form bullae that later ruptured. Dermatological 
examination revealed well demarcated    erosions involving bilateral axilla, upper and inner 
thighs and genitalia with dusky hue of the surrounding skin (figure 1a, b, c). There was 
erosions and crusting of lips and oral mucosa. Complete hemogram, peripheral smear, 
absolute eosinophil count, liver and renal function tests, chest radiography and ultrasound 
abdomen were within normal limits. Biopsy from the thigh lesion revealed liquefactive 
degeneration of the basal cell layer and an inflammatory infiltrate in the upper dermis 
(figure 2a, b). The patient was diagnosed as SDRIFE due to diclofenac   and was advised to 
avoid the drug. He was treated with 30mg of prednisolone daily for three days tapered over 
2 weeks. He showed dramatic improvement with complete resolution of symptoms in 2 
weeks time but with residual hyperpigmentation.  
One year later he came back to us with similar lesions involving both axillae, groins and 
genitalia however of less intensity(figure 3a,b). The patient gave a history of taking a single 
dose of diclofenac   just prior to the eruption. The skin lesions responded to systemic 
steroids and healed leaving hyperpigmentation. 
DISCUSSION 
The term SDRIFE   or symmetrical drug related intertriginous and flexural exanthema has 
recently replaced the old and ethically problematic term “baboon syndrome” (BS), a specific 
skin eruption resembling the red gluteal area of baboons after systemic exposure to contact 
allergens such as mercury and nickel [1]. A similar reaction pattern can be precipitated by 
systemically administered drugs like aminopencillins, beta lactum antibiotics, 
chemotherapeutic agents and radiocontrast media.  For most of these causative drugs, prior 
cutaneous sensitization or possible cross-sensitization has not been observed [2]. The usual 
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latent period between onset of drug intake and onset of symptoms vary from hours  as in 
our patient  to 2 days, though longer intervals have been documented [3] [4].                              
Flexural predilection has been explained in SDRIFE due to the collection of the causative 
agent in eccrine or apocrine glands, or  increased temperature or friction. Another postulate 
is a recall phenomenon eliciting a T-cell mediated, delayed type hypersensitivity reaction in 
areas of prior dermatitis.  Recently, a novel pathological mechanism, the pi concept 
(pharmacologic interaction with immunoreceptors) has been suggested to be involved in 
the direct binding of drugs  noncovalently to a fitting T-cell receptor  without prior 
metabolism and therefore  reactions occur on first exposure to a drug [5]. 
Hausermann et al. have proposed 5 diagnostic criteria for SDRIFE: 1) exposure to a 
systemically administered drug either at the first or repeated dose (excluding contact 
allergens); 2) sharply demarcated erythema of the gluteal/perianal area and/or V-shaped 
erythema of the inguinal/perigenital area; 3) involvement of at least one other 
intertriginous/flexural localization; 4) symmetry of the affected areas; and 5) absence of 
systemic symptoms or signs all of which were satisfied by our patient. Bullous lesions 
superimposed on erythema leading to erosions as occurred in our case has been previously 
reported in SDRIFE [6]. Other skin manifestations reported include papules and pustules 
over the flexural exanthema, coexistent maculopapular rash on other areas or targetoid 
lesions on palms and soles. The involvement of face and mucosa has been rarely reported 
[7]. 
The two latter features in the criteria distinguish SDRIFE from other drug reactions like 
DRESS (Drug rash with eosinophilia and systemic symptoms), TEN (Toxic epidermal 
necrolysis) and AGEP (Acute generalised exanthematous pustulosis). FDE (Fixed drug 
eruption) usually appears as a solitary or multiple well circumscribed, erythematous 
macules or plaques with or without bulla and these lesions typically recur at the same sites 
with each administration of the causative drug, and on discontinuation resolve leaving 
hyperpigmentation. The most commonly affected sites are the lips, palms, soles, glans 
penis, and groin areas [8]. The presence of bullous lesions with subsequent erosions, 
residual hyperpigmentation, mucosal involvement and typical recurrence at the same site in 
our case resembled FDE, but the classical symmetry of lesions involving the flexures was a 
distinguishing feature.  
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A single case of SDRIFE with overlapping features of FDE has been reported with 
amoxycyllin. The overlap could be due to the common IVc type of delayed hypersensitivity 
reaction involving CD4+ and CD8+ cells in both SDRIFE and FDE [9]. 
A rare nonpigmenting form   of FDE is known to occur as   symmetrical, large, erythematous 
lesions on the buttocks and the major flexural and intertriginous areas mimicking SDRIFE 
[10].  
Histology of SDRIFE is variable and nonspecific. Commonest histology observed is superficial 
perivascular inflammatory infiltrate typically composed of lymphocytes or eosinophils.  
Kerainocyte necrosis with interphase dermatitis resembling erythema multiforme has been 
documented earlier. Delayed intradermal, patch and lymphocyte transformation tests have 
yielded variable results. Controlled oral provocation test is the most reliable diagnostic aid, 
but has to be performed cautiously for fear of severe reactions. But our patient   developed 
less severe reaction on second exposure, probably due to the rapid withdrawal of the culprit 
drug. 
SDRIFE is a self limiting condition and simple withdrawal of the culprit drug achieves 
resolution in 2-3 weeks. Treatment is often symptomatic, though topical or systemic 
steroids may hasten recovery as in our case. [3]  
We report this case to highlight occurrence of SDRIFE mimicking FDE induced by diclofenac 
which has not been reported earlier. The common features shared by both the condition 
raises a question, could SDRIFE be a flexural variant of FDE.   
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